This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The PISC was delivered at the institution where the surgery was due to take place, six to eight weeks before surgery was scheduled. The PICS consisted of an initial interview and brief weekly contacts with a specialised nurse plus nicotine replacement therapy for six weeks.
Location/setting
France/hospital.
Methods

Analytical approach:
The analysis used a Markov model with a short time horizon. The authors stated that it was carried out from the perspective of the payer.
Effectiveness data:
The clinical evidence for the model came from a randomised controlled trial (RCT), which was identified through a search of original articles on preoperative smoking cessation listed in three published systematic reviews, two of which were from the Cochrane Database of Systematic Reviews. The RCT included 120 smokers and the primary endpoint was the rate of smoking cessation in the PISC and control groups. The main outcome for this study was the rate of complications after surgery.
Monetary benefit and utility valuations:
Not included.
Measure of benefit:
No summary benefit measure was used. The key clinical inputs were the smoking cessation rate and the rate of complications after surgery, which were derived from the RCT.
Cost data:
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The economic analysis considered two key categories of costs, which were the delivery of the PISC and the length of hospital stay. The intervention delivery included management by a specialised nurse, a smoking status test, and the nicotine replacement therapy. The length of hospital stay included the stay on the orthopaedic ward, in intensive care, and on other medical or surgical wards, as reported in the RCT. The cost of the hospital stay was calculated using official rates in French hospitals and diagnosis-related group data. Extra days of stay were rated according to the ward. The cost of nicotine replacement therapy was estimated through a survey of 30 pharmacies in Paris. All costs were in Euros (EUR) and the price year was 2008.
Analysis of uncertainty:
A series of one-way sensitivity analyses was carried out by varying the length of stay in various wards, cost of stay in intensive care or orthopaedic ward, and rate of complications. The alternative assumptions appear to have been based on authors' opinions.
Results
The probability of complications was 1/56 with the intervention and 6/52 without. The smoking cessation rate was 64% with the intervention and 7.7% without.
The hospital costs per patient were EUR 6,246 with the intervention and EUR 6,559 without. The cost of the PISC was EUR 196 per patient, the reduction in hospital costs was EUR 313, and the savings associated with the intervention were EUR 117.
The sensitivity analysis indicated that the length of stay in intensive care and the rate of complications were the most influential inputs. The cost of the PISC was higher than the savings in hospital costs only when the rate of complications with the intervention was increased from 1/56 to 4/56.
